In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EraGen Biosciences Inc.

Division of Luminex Corp.
www.eragen.com

Latest From EraGen Biosciences Inc.

Deals Shaping the Medical Industry (07/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.

EraGen Biosciences

EraGen is developing hardware and software tools for genomics analysis including Master Catalog, a web-based tool that combines genomic database organization and search capabilities with evolutionary biological information, and AEGIS, a technology for direct DNA detection without the need for target amplification.
BioPharmaceutical Medical Device

Selected Start-Ups Founded in 2000 (0002)

{In Vivo} summarizes the technologies of several medical companies founded recently, including Belgium's [AlgoNomics NV], a new entrant in the biocomputing and bioinformatics arena. [CoPharma Inc.]'s mission is to develop drug and biological products through joint ventures with discovery firms. Launched in February 2000 with $2 million from Sanderling, Alta Partners and Graystone, [Cythera Inc.] will develop therapies based on the transplantation of functional human cells grown{ in vitro}, offering an alternative to the use of donated human tissues. [Embolic Protection Inc.] has developed a device, consisting of a guide wire and filter mechanism, to remove embolic debris. Denmark's [NsGene A/S] is a joint venture of NeuroSearch A/S and the University of Lund. [WebEBM] will offer evidence-based clinical guidelines for 400 diseases or conditions on its website.
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Sulfonics Inc
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Luminex Corp.
  • Senior Management
  • Irene Hrusovsky, MD, Pres. & CEO
    Linda P Fleming, CFO
    Scott C Johnson, PhD, VP, Prod. Dev.
  • Contact Info
  • EraGen Biosciences Inc.
    Phone: (877) 885-6617
    918 Deming Way
    Ste. 201
    Madison, WI 53717-1944
    USA
UsernamePublicRestriction

Register